News
Got $5,000? These 3 Stocks Are Deep-Value Buys Right Now
A $5,000 investment may not seem a significant amount to some, but it can generate tremendous returns in the long run. If you were to invest in the S&P 500, which averages an annual return of around
Humana Announces $500K Investment in the Virginia Health Care Foundation to Boost Behavioral Health Workforce Development and Support
Leading health and well-being company Humana today announced a meaningful investment of $500,000 in the Virginia Health Care Foundation (VHCF). This funding will bolster crucial behavioral health
Dexcom G7, the Smallest, Most Accurate, Easy-to-Use CGM Now Connects to the Tandem t:slim X2 Insulin Pump
DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring (CGM) System now
Dexcom G7, the Smallest, Most Accurate, Easy-to-Use CGM Now Connects to the Tandem t:slim X2 Insulin Pump
DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring (CGM) System now
EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius retains relief payments for hospitals of up to €300 million (from the current perspective) and is therefore subject to a ban on dividends and bonuses for 2023
A Bull Market Is Coming: 2 Top Stocks to Buy Hand Over Fist
Are we currently in a bull market? Some argue that we are. In early June, the S&P 500 closed 20% up from its most recent low, which is the technical definition of a bull market. However, equities
Humana Foundation Awards Health Equity Research Grants Equal to $1 Million to Three University Partners
The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 41 years, today announced the recipients of its first-ever research grants in service of the Foundation’s health
EQS-News: Gerresheimer AG: Guido Pickert to head up Investor Relations at Gerresheimer
Medtronic Stock: Bull vs. Bear
Medtronic (NYSE: MDT) is a medical device giant that has generated billions of dollars in earnings over time thanks to its diabetes, cardiovascular, neuroscience, and medical-surgical platforms. The
EQS-News: Gerresheimer: Green electricity from wind for German production sites
Is Medtronic a Good Dividend Stock to Buy Now?
If you're looking for reliable dividend stocks, they don't get much better than Medtronic (NYSE: MDT). The medical device company has raised its dividend payout for 46 consecutive years.
From 1978
$1,000 Invested in These 3 Dividend Stocks Could Make You Rich
There are lots of get-rich-quick schemes out there. Unfortunately, most lose their investors' money rather than make them rich. A far better approach is to take things slow and grow your wealth over
If I Could Only Buy 1 Stock Right Now, This Would Be It
Medtronic (NYSE: MDT) is a stock I bought and have added to several times. I'm not a healthcare-focused investor, but the stock's historically high 3.6% dividend yield and long history of annual
Why Medtronic Stock Trounced the Market on Tuesday
Medical-devices company Medtronic's (NYSE: MDT) stock was in good health on Tuesday. Following the company's release of its latest set of quarterly figures, investors traded it up by nearly 5%. That
Medtronic (MDT) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Medtronic (NYSE: MDT)Q2 2024 Earnings CallNov 21, 2023, 8:00 a.m. ET
Ryan Weispfenning
Source Fool.com
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA: Favorable settlement agreement with U. S. government with positive earnings impact of approx. EUR 175 million – 2023 earnings outlook raised
Ozempic Might Be Helping Abbott Laboratories and DexCom Stock. Here's How.
Novo Nordisk's (NYSE: NVO) Ozempic is indicated to treat diabetes, and its wild success and household name is making a few cardiometabolic device companies rather nervous. With a powerful tool to
Ozempic Might Be Helping Abbott Laboratories and DexCom Stock. Here's How.
Novo Nordisk's (NYSE: NVO) Ozempic is indicated to treat diabetes, and its wild success and household name is making a few cardiometabolic device companies rather nervous. With a powerful tool to
2 Stock Split Growth Stocks to Buy and Hold
Last year, tech giant Amazon (NASDAQ: AMZN) and medical device specialist DexCom (NASDAQ: DXCM) were among the several high-profile companies to conduct stock splits. This move attracted plenty of
2 Stock Split Growth Stocks to Buy and Hold
Last year, tech giant Amazon (NASDAQ: AMZN) and medical device specialist DexCom (NASDAQ: DXCM) were among the several high-profile companies to conduct stock splits. This move attracted plenty of
Is DexCom the Next Big Growth Stock?
With shares of DexCom (NASDAQ: DXCM) falling 11% this year amid a steadily rising market, one might think that the medical device maker's growth potential is ebbing compared to its former glory. But
Is DexCom the Next Big Growth Stock?
With shares of DexCom (NASDAQ: DXCM) falling 11% this year amid a steadily rising market, one might think that the medical device maker's growth potential is ebbing compared to its former glory. But
Could DexCom Stock Help You Become a Millionaire?
Getting to $1 million is a great long-term goal for investors to target. Not only could that be a good nest egg to tap into during retirement, but you could also use that money to invest in dividend
Could DexCom Stock Help You Become a Millionaire?
Getting to $1 million is a great long-term goal for investors to target. Not only could that be a good nest egg to tap into during retirement, but you could also use that money to invest in dividend
Where Will Medtronic Stock Be in 5 Years?
The past five years haven't been great for medical device maker Medtronic (NYSE: MDT). Normally investors would expect a stock to generate positive gains over a five-year period, but Medtronic's